tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma
A novel liquid biopsy candidate in blood shows promise for liver cancer diagnosis and treatment monitoring in early studies.
This discovery study identifies a novel serum tsRNA (tRF-34-P4R8YP9LON4VHM) as a liquid biopsy candidate for HCC diagnosis, with evidence for staging correlation and post-surgical response monitoring. The biomarker requires prospective validation in larger independent cohorts.
What the study was
- Study design
- Observational diagnostic biomarker study
- Population
- HCC patients, hepatitis patients, and healthy controls
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Scientific Reports
Why it surfaced
Novel tsRNA liquid biopsy candidate for HCC; discovery stage with sample size not reported; interesting but exploratory only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.